Circio Holding ASA Logo

Circio Holding ASA

Clinical-stage company developing circular RNA medicines and immunotherapies.

CRNA | OL

Overview

Corporate Details

ISIN(s):
NO0012858564 (+5 more)
LEI:
5967007LIEEXZXFYNS31
Country:
Norway
Address:
Vollsveien 19, 1366 Lysaker

Description

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
Norwegian 527.3 KB
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
Norwegian 529.3 KB
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
English 1.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
Norwegian 527.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
Norwegian 529.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
English 1.2 KB
2025-12-19 14:24
Circio Holding ASA Notice of extraordinary general meeting on 12 January 2026…
Norwegian 677.7 KB
2025-12-19 14:24
Circio Holding ASA Notice of extraordinary general meeting on 12 January 2026
English 5.5 KB
2025-12-08 10:00
Circio Holding ASA Key information related to the rights issue
English 9.3 KB
2025-12-08 07:00
Circio announces 88% underwritten and presubscribed NOK 50 million rights issue…
English 18.4 KB
2025-12-03 15:23
Corr*: Atlas Holdings for CIRCIO
English 854 bytes
2025-12-03 12:36
Atlas Holdings for CIRCIO
English 840 bytes
2025-11-25 15:22
Atlas Holdings for CIRCIO
English 815 bytes
2025-11-24 07:00
Circio presents data that further strengthens and broadens its circVec circular…
English 4.3 MB
2025-11-24 07:00
Circio presents data that further strengthens and broadens its circVec circular…
English 7.9 KB

Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Circio Holding ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Circio Holding ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Elicio Therapeutics, Inc. Logo
Clinical-stage biotech developing lymph node-targeted immunotherapies for cancer.
United States of America
ELTX
E-Novia Logo
A venture studio and consultancy that transforms Physical AI research into products.
Italy
E9IA
Ensysce Biosciences, Inc. Logo
Clinical-stage pharma firm developing abuse-deterrent drugs for severe pain.
United States of America
ENSC
Enveric Biosciences, Inc. Logo
Develops novel small-molecule therapeutics for neuropsychiatric disorders.
United States of America
ENVB
Eone Diagnomics Genome Center Co., Ltd. Logo
A healthcare company specializing in genetic analysis for personalized medicine.
South Korea
245620
Develops hair loss therapies and provides preclinical CRO services.
South Korea
446440
Equillium, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune & inflammatory disorders.
United States of America
EQ
Eurofins-Cerep Logo
Contract research organization for pre-clinical in vitro drug discovery services.
France
ALECR
Evaxion A/S Logo
A clinical-stage TechBio company developing immunotherapies using an AI platform.
United States of America
EVAX
Evogene Ltd. Logo
A computational biology company using AI to develop life-science products.
Israel
EVGN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.